Septerna, Inc.
Key Metrics
Market Snapshot
About
Septerna, Inc. is a clinical-stage biotechnology company focused on discovering and developing oral small molecule drugs for G protein-coupled receptor targets. The company utilizes a proprietary Native Complex Platform to unlock challenging GPCR targets across various therapeutic areas. Septerna aims to create transformative medicines for patients with significant unmet medical needs.